59: Colchicine Efficacy and Safety After Myocardial Infarction
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
This episode does a deep dive into a clinical trial article, "Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction." The study, known as the COLCOT trial, was a randomized, double-blind, placebo-controlled trial involving 4745 patients who had recently suffered a myocardial infarction, aiming to evaluate the effectiveness of low-dose colchicine, an anti-inflammatory medication, in preventing subsequent ischemic cardiovascular events.
Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497-2505. doi:10.1056/NEJMoa1912388.
Follow Dr. Anthony Novello, PT, DPT
@anthonynovello.dpt